Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Docetaxel × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

OTHER 183 INDUSTRY 58 NETWORK 9 OTHER_GOV 7 NIH 5 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Sarcoma 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

S 1 (combination) 15 Paclitaxel 10 Oxaliplatin 10 Capecitabine 9 Irinotecan 6 Cisplatin 6 titanium silicide 4 sintilimab 4 nimotuzumab 3 nedaplatin 3 TP protocol 3 HMPL-013 3 Fluorouracil 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 toripalimab 2 raltitrexed 2 Trastuzumab 2 Tegafur 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Adjuvant 2 Radiosurgery 2 Radiation 2 Neoadjuvant Therapy 2 Leucovorin 2 Chemotherapy, Adjuvant 2 Albumin-Bound Paclitaxel 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02725424 2022-08-17

MATCH

ChineseAMS

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡